neurocare group is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 2025.
neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS)...
neurocare group expands mental health care reach through acquisition of Smart TMS clinics in the UK, offering innovative personalized...
neurocare group expands mental health care reach through acquisition of Smart TMS clinics in the UK, offering innovative personalized...

Kontakt

Kontaktieren Sie uns, um mehr über Innovationen in den Bereichen Mental Health und Performance zu erfahren

Kontakt Kontakt